Therapeutic drug monitoring of LAI antipsychotics as a predictor of clinical relapse: a one-year follow-up

INTRODUCTION: Clinical relapses in schizophrenia remain a frequent event. Long-acting injectable (LAI) antipsychotics enhance adherence, but low blood levels can sometimes be observed despite an adequate posology. Nonetheless, the evaluation of this parameter is uncommon in clinical practice. OBJECT...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Anna, G., Rotella, F., Ballerini, A., Ricca, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563214/
http://dx.doi.org/10.1192/j.eurpsy.2022.520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563214/
http://dx.doi.org/10.1192/j.eurpsy.2022.520

Ejemplares similares